paclitaxel has been researched along with Leukemia, Megakaryocytic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
deFazio, A; Guminski, AD; Harnett, PR | 1 |
1 other study(ies) available for paclitaxel and Leukemia, Megakaryocytic
Article | Year |
---|---|
Carboplatin and paclitaxel interact antagonistically in a megakaryoblast cell line--a potential mechanism for paclitaxel-mediated sparing of carboplatin-induced thrombocytopenia.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Division; Cell Survival; DNA Adducts; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Humans; Leukemia, Megakaryoblastic, Acute; Paclitaxel; Thrombocytopenia; Tumor Cells, Cultured | 2001 |